title: Botulinum toxin A injections improve apraxia of eyelid opening without overt blepharospasm associated with neurodegenerative diseases.
authors.forename: Eva
authors.initials: E
authors.lastname: Lopez Valdes
authors.forename: Ignacio Javier
authors.initials: IJ
authors.lastname: Posada Rodriguez
authors.forename: Rafael
authors.initials: R
authors.lastname: Bilbao-Calabuig
mesh_terms: D001072:Apraxias / Q000150:complications / Q000188:drug therapy* / Q000503:physiopathology; D001764:Blepharospasm / Q000150:complications / Q000503:physiopathology*; D019274:Botulinum Toxins, Type A / Q000008:administration & dosage*; D006801:Humans; D007267:Injections; D019636:Neurodegenerative Diseases / Q000150:complications / Q000503:physiopathology*; D016896:Treatment Outcome
chemical_list: D019274:Botulinum Toxins, Type A